Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|February 20, 2017
Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanomaLisa Zimmer, Susmitha Apuri, Zeynep Eroglu, et al.
Mayo Clinic Proceedings|April 10, 2007
Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatmentSvetomir N Markovic, Lori A Erickson, Ravi D Rao, et al.
JCO Clinical Cancer Informatics|October 28, 2020
Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT TrialEthan Basch, Angela M Stover, Deborah Schrag, et al.
Plos One|March 21, 2020
Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutationsThomas T DeLeon, Daniel R Almquist, Benjamin R Kipp, et al.
Mayo Clinic Proceedings|March 14, 2007
Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosisSvetomir N Markovic, Lori A Erickson, Ravi D Rao, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2025
NeoACTIVATE Arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable Stage III melanomaTina J Hieken, David Zahrieh, Thomas J Flotte, et al.
American Journal of Clinical Oncology|April 9, 2013
Rare presentations of primary melanoma and special populations: a systematic reviewLisa A Kottschade, Travis E Grotz, Roxana S Dronca, et al.
The New England Journal of Medicine|March 25, 2026
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon CancerFrank A Sinicrope, Fang-Shu Ou, Dirk Arnold, et al.
Annals of Surgical Oncology|November 22, 2024
Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-institutional CohortKelsey B Montgomery, M Chandler McLeod, Danielle K DePalo, et al.
Current Oncology (Toronto, Ont.)|July 27, 2026
Real-World Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Treatment Delivery, Immune Reconstitution, and Cardiac Monitoring During High-Dose IL-2Mohamed A Aboelatta, Jabra Zarka, Nika Tchatchua, et al.
Pageof 7